Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) , there is growing interest in exploring the
potential of lncRNAs as diagnostic and prognostic biomarkers, as well
LIU, Z.,
ZHANG, R.,
CHEN, X.,
YAO, P.,
YAN, T.,
LIU, W.,
YAO, J.,
ZHAO, S.,
SOKHATSKII, A.,
GAREEV, I. (2019) , to act as therapeutic targets, and to identify
potential small-molecule compounds for treating ICH
LV, L.,
ZHANG, L.,
LI, R.,
LI, Y.,
YANG, R.,
LI, C.,
FANG, R.,
SHABANOVA, A.,
LI, X.,
LIU, Y.,
LIANG, H.,
ZHOU, Y.,
SHAN, H.,
ZHENG, N. (2020) potential mechanism. Cardiac-specific microRNA-1 (miR-1) transgenic (TG) and myocardial infarction (MI
of economic socialization, identified by socializing
potential of the educational environment in technological
Han, Z.B.,
Wang, X.X.,
Xu, Z.H.,
Cao, Y.,
Gong, R,
Zagidullin, N.,
Sukhareva, N.,
Zhang, Y. (2021) for tissue development and pathogenesis. However, the
potential involvement of m(6)A in the regulation
by this defense system have
potentiated the activity of ribozymes in the composition of ribonucleoproteins (RNPs
Paar, V.,
Jirak, P.,
Larbig, R.,
Zagidullin, N.S.,
Brandt, M.C.,
Lichtenauer, M.,
Hoppe, U.C.,
Motloch, L.J. (2019) in action
potential generation and cardiac contraction, Ca2+ channels and Ca2+ handling proteins represent
FACHAL, L.,
KAR, S.,
TYRER, J.P.,
GHOUSSAINI, M.,
HARRINGTON, P.A.,
HEALEY, C.S.,
MAYES, R.,
SHAH, M.,
PHAROAH, P.D.P.,
EASTON, D.F.,
DUNNING, A.M.,
ASCHARD, H.,
JIANG, X.,
TAMIMI, R.M.,
KHUSNUTDINOVA, E.,
BIAŁKOWSKA, K.,
и др. соавторы (2020) to determine variants with high posterior probabilities of being causal.
Potentially causal variants were